0 items USD 0.00Search
Your search for "technavio global neuropathy pain treatment market 2017 2021" gave back 1596742 results.
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling...
Catalog:
MRRPB5
November 2023
Price: USD 4,350.00
Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule...
Catalog:
Global Markets Direct
July 2022
Price: USD 3,500.00
Diabetic Neuropathy (Metabolic Disorder) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
Catalog:
Global Markets Direct
October 2021
Price: USD 2,000.00
Adenosine Receptor A3 (ADORA3) - Pipeline Review, H1 2018 Summary Adenosine Receptor A3 (ADORA3) - The adenosine A3 receptor, also known as ADORA3,...
Catalog:
Global Markets Direct
March 2018
Price: USD 3,500.00
Neuropathic pain therapeutics refers to a way to relieve and treat neuropathic pain through various drugs or treatments. Neuropathic pain is a...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) – Pipeline Review, H1 2018 Summary Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) pipeline Target...
Catalog:
Global Markets Direct
February 2018
Price: USD 3,500.00
Neuropathic pain therapeutics refers to a way to relieve and treat neuropathic pain through various drugs or treatments. Neuropathic pain is a...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Neuropathic pain therapeutics refers to a way to relieve and treat neuropathic pain through various drugs or treatments. Neuropathic pain is a...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Tumor Necrosis Factor Receptor Superfamily Member 16 - Pipeline Review, H1 2020 Summary Tumor Necrosis Factor Receptor Superfamily Member 16 (Low...
Catalog:
Global Markets Direct
February 2020
Price: USD 3,500.00
Tumor Necrosis Factor Receptor Superfamily Member 16 - Pipeline Review, H2 2019 Summary Tumor Necrosis Factor Receptor Superfamily Member 16 (Low...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Highlights The global Painful Diabetic Neuropathy Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
Beta Nerve Growth Factor (Beta NGF or NGF) - Pipeline Review, H1 2018 Summary According to the recently published report 'Beta Nerve Growth...
Catalog:
Global Markets Direct
April 2018
Price: USD 3,500.00
Tumor Necrosis Factor Receptor Superfamily Member 16 (Low Affinity Neurotrophin Receptor p75NTR or Low Affinity Nerve Growth Factor Receptor or Gp80...
Catalog:
Global Markets Direct
June 2018
Price: USD 3,500.00
Optic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's...
Catalog:
Global Markets Direct
April 2022
Price: USD 2,000.00
